The Challenges of Diagnosing Mesothelioma

ByHolly Zink
The Challenges of Diagnosing Mesothelioma

The case of a 67-year-old man complaining of abdominal pain is a sobering example of the challenges of diagnosing malignant peritoneal mesothelioma.

Malignant mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the body’s internal organs. When mesothelioma grows in the lining of the abdomen, it’s called malignant peritoneal mesothelioma.

Malignant mesothelioma is generally caused by exposure to asbestos. This exposure usually happens on the job, and it can take years for symptoms to appear.

In this case, the elderly man went to the emergency room for help with abdominal pain. This pain had been getting worse over the last month. He was also experiencing shortness of breath and fatigue.

After a physical examination, his doctor ordered a CT scan of his abdomen. A CT scan is a type of x-ray that creates a 3D image of the inside of the body. It can be helpful when doctors are trying to see if there are any tumors like mesothelioma.

However, the CT scan didn’t show any unusual growths.

Diagnosis and Testing Methods

Mesothelioma can be hard to diagnose. It can take decades for outward symptoms to appear after a person has been exposed to asbestos. It is also a rare disease, which means doctors don’t often think to look for mesothelioma in sick patients.

Because of these challenges, doctors must use more than one diagnostic method. One of these is imaging test like CT scans and x-rays.

Another method is testing fluid. When organ tissue is healthy, it produces a lubricating fluid. When this tissue becomes cancerous, it produces too much fluid. Doctors can test this fluid to look for cancer cells.

This is exactly what our patient’s doctor did next. They removed a sample of fluid from the patient’s abdomen and tested it for cancer cells. They found cells that looked like they could be cancerous mesothelioma cells.

Gold Standard Diagnosis for Mesothelioma

The gold standard of mesothelioma diagnosis is a tissue biopsy. This is when doctors take a sample of the suspected cancer tissue for closer examination.

This is what the patient’s doctor did to confirm the mesothelioma diagnosis. They took a sample of tissue from the patient’s abdomen and tested it for mesothelioma.

Sure enough, the tissue sample confirmed that the patient had malignant peritoneal mesothelioma.

This case study is all too typical of what mesothelioma patients go through to reach a diagnosis. Better diagnostic methods are needed to help these patients get the care they need.

Source

Dusseault SK, Okobi OE, Thakral N, et al. Primary Peritoneal Mesothelioma: Diagnostic Challenges of This Lethal Imposter. Case Rep Gastroenterol. 2022;16(3):588-594. Published 2022 Nov 8. doi:10.1159/000523935. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830302/

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    ByAlex Strauss

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    ByAlex Strauss

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

  • | |

    Mesothelioma Surgeons Report New Biopsy Technique

    ByAlex Strauss

    A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…

  • |

    New Serum Marker Could Improve Mesothelioma Diagnosis

    ByAlex Strauss

    Japanese researchers believe they have found a way to diagnose a rare form of mesothelioma earlier using a simple blood test. Diffuse malignant peritoneal mesothelioma (DMPM), which represents about a fourth of all mesothelioma cases, is an aggressive malignancy that spreads across the lining of the abdomen. In most cases, DMPM is lethal within a year. The standard treatment for diffuse malignant peritoneal mesothelioma is cytoreductive surgery to remove as much of the mesothelioma as possible, followed by intraperitoneal chemotherapy to destroy residual cancer cells. In some studies, this approach has resulted in 5-year survival rates of 30 to 60 percent. However, it is most successful when it is performed early, while the primary mesothelioma tumor is more easily removed. Like all forms of…